Search Results - Jamileh Moghimi
- Showing 1 - 1 results of 1
-
1
Is it the time to offer rituximab as a cost-benefit treatment for immunoglobulin A nephropathy? A short-review to current concepts by Mohammad-Reza Tamadon, Jamileh Moghimi, Hamed Rezaei
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book